Signalling through IGF-I and insulin receptors: Where is the specificity?

Growth Hormone and IGF Research

Volumn 12, Issue 2, 2002, Pages 84-90

  Kim, Jane J ^a   Accili, Domenico ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b Berrie Research Pavilion   (United States)

Author keywords

Genetics; Growth; Metabolism; Mouse models; Substrate phosphorylation

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; SOMATOMEDIN C RECEPTOR; INSULIN; SOMATOMEDIN C;

CELL CULTURE; DEVELOPMENT; GENE FUNCTION; GROWTH; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; TISSUE DISTRIBUTION; ANIMAL; BIOLOGICAL MODEL; CELL LINE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CELL LINE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0036550234     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.2002.0265     Document Type: Review

References (61)

1. Ullrich A, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985; 313: 756-761.
2. Ullrich A, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986; 5: 2503-2512.
3. Hubbard SR. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 1997; 16: 5572-5581.
4. Louvi A, Accili D, Efstratiadis A. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 1997; 189: 33-48.
5. Accili D, et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 1996; 12: 106-109.
6. Joshi RL, et al. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 1996; 15: 1542-1547
7. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993; 75: 59-72.
8. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 1999; 23: 32-40.
9. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 1996; 177: 517-535.
10. Fernandez A, et al. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 2001; 15: 1926-1934.
11. Bruning JC, et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 1998; 2: 559-569.
12. Lauro D, et al. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat Genet 1998; 20: 294-298.
13. Di Cola G, Cool MH, Accili D. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest 1997; 99: 2538-2544.
14. Shefi-Friedman L, Wertheimer E, Shen S, Bak A, Accili D, Sampson SR. Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice. Am J Physiol Endocrinol Metab 2001; 281: E16-E24.
15. Baudry A, et al. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells. FEBS Lett 2001; 488: 174-178.
16. Rother KI, Imai Y, Caruso M, Beguinot F, Formisano P, Accili D. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem 1998; 273: 17491-17497.
17. Park BC, Kido Y, Accili D. Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes. Biochemistry 1999; 38: 7517-7523.
18. Kim JJ, Park BC, Kido Y, Accili D. Mitogenic and metabolic effects of type I IGF receptor overexpression in insulin receptor-deficient hepatocytes. Endocrinology 2001; 142: 3354-3360.
19. Accili D, Kido Y, Nakae J, Lauro D, Park B-C. Genetics of type 2 diabetes: insights from targeted mouse mutants. Curr Mol Med 2001; 1: 9-23.
20. De Meyts P, Urso B, Christoffersen CT, Shymko, RM. Mechanism of insulin and IGF-I receptor activation and signal transduction specificity. Receptor dimer cross-linking, bell-shaped curves, and sustained versus transient signaling. Ann NY Acad Sci 1995; 766: 388-401.
21. Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 1998; 140: 19-24.
22. Yakar S, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 1999; 96: 7324-7329.
23. Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 1996; 10: 413-427.
24. Frasca F, et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 1999; 19: 3278-3288.
25. Andersen AS, Wiberg FC, Kjeldsen T. Localization of specific amino acids contributing to insulin specificity of the insulin receptor. Ann NY Acad Sci 1995; 766: 466-468.
26. Yamaguchi Y, Flier JS, Benecke H, Ransil BJ, Moller DE. Ligand-binding properties of the two isoforms of the human insulin receptor. Endocrinology 1993; 132: 1132-1138.
27. Zhang B, Roth RA. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor. Biochemistry 1991; 30: 5113-5117.
28. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000; 103: 211-225.
29. Kohanski RA. Insulin receptor autophosphorylation. II. Determination of autophosphorylation sites by chemical sequence analysis and identification of the juxtamembrane sites. Biochemistry 1993; 32: 5773-5780.
30. O'Connor R, et al. identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 1997; 17: 427-435.
31. Kato H, Faria TN, Stannard B, Roberts CT Jr, LeRoith D. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol Endocrinol 1994; 8: 40-50.
32. Kato H, Faria TN, Stannard B, Roberts CT Jr, LeRoith D. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). J Biol Chem 1993; 268: 2655-2661.
33. Xu B, Bird VG, Miller WT. Substrate specificities of the insulin and insulin-like growth factor 1 receptor tyrosine kinase catalytic domains. J Biol Chem 1995; 270: 29825-29830.
34. Sawka-Verhelle D, Tartare-Deckert S, White MF, Van Obberghen E. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. J Biol Chem 1996; 271: 5980-5983.
35. He W, et al, Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2. J Biol Chem 1996; 271: 11641-11645.
36. Tornqvist HE, Pierce MW, Frackelton AR, Nemenoff RA, Avruch J. Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem 1987; 262: 10212-10219.
37. Van Horn DJ, Myers MG Jr, Backer JM. Direct activation of the phosphatidylinositol 3′-kinase by the insulin receptor. J Biol Chem 1994; 269: 29-32.
38. Peruzzi F, et al. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 1999; 19: 7203-7215.
39. Valentinis B, et al, Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem 1999; 274: 12423-12430.
40. Faria TN, Blakesley VA, Kato H, Stannard B, LeRoith D, Roberts CT Jr. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function. J Biol Chem 1994; 269: 13922-13928.
41. Urso B, et al, Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J Biol Chem 1999; 274: 30864-30873.
42. Kalloo-Hosein HE, Whitehead JP, Soos M, Tavare JM, Siddle K, O'Rahilly S. Differential signaling to glycogen synthesis by the intracellular domain of the insulin versus the insulin-like growth factor-1 receptor. Evidence from studies of TrkC-chimeras. J Biol Chem 1997; 272: 24325-24332.
43. Lammers R, Gray A, Schlessinger J, Ullrich A. Differential signalling potential of insulin- and IGF-1 -receptor cytoplasmic domains. EMBO J 1989; 8: 1369-1375.
44. Myers MJ, et al. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 1993; 132: 1421-1430.
45. Xu P, Jacobs AR, Taylor SI. Interaction of insulin receptor substrate 3 with insulin receptor, insulin receptor-related receptor, insulin-like growth factor-1 receptor, and downstream signaling proteins. J Biol Chem 1999; 274: 15262-15270.
46. Najjar SM, Blakesley VA, Li Calzi S, Kato H, LeRoith D, Choice CV. Differential phosphorylation of pp 120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. Biochemistry 1997; 36: 6827-6834.
47. Soni P, Lakkis M, Poy MN, Fernstrom MA, Najjar SM. The differential effects of pp 120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor. Mol Cell Biol 2000; 20: 3896-3905.
48. Beitner-Johnson D, LeRoith D. Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. J Biol Chem 1995; 270: 5187-5190.
49. Furlanetto RW, Dey BR, Lopaczynski W, Nissley SP. 14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor. Biochem J 1997; 327: 765-771.
50. Craparo A, Freund R, Gustafson TA. 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J Biol Chem 1997; 272: 11663-11669.
51. O'Neill TJ, Zhu Y, Gustafson TA. Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation. J Biol Chem 1997; 272: 10035-10040.
52. Laviola L, et al. The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts. J Clin Invest 1997; 99: 830-837.
53. He W, Rose DW, Olefsky JM, Gustafson TA. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains. J Biol Chem 1998; 273: 6860-6867.
54. Ligensa T, et al. A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor. J Biol Chem 2001; 276: 33419-33427.
55. Nakae J, Barr V, Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 2000; 19: 989-996.
56. Nakae J, Kitamura T, Ogawa W, Kasuga M, Accili D. Akt-independent pathways for insulin regulation of gene expression through the forkhead transcription factor FKHR. Biochemistry 2001; 40: 11768-11776.
57. Dalle S, Ricketts W, Imamura T, Vollenweider P, Olefsky JM. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J Biol Chem 2001; 276: 15688-15695.
58. Maina F, et al. Coupling Met to specific pathways results in distinct developmental outcomes. Mol Cell 2001; 7: 1293-1306.
59. Partanen J, Schwartz L, Rossant J. opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev 1998; 12: 2332-2344.
60. Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility. Nat Genet 2000; 24: 157-162.
61. Klinghoffer RA, Mueting-Nelsen PF, Faerman A, Shani M, Soriano P. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol Cell 2001; 7: 343-354.